Concepedia

Publication | Closed Access

Eprodisate for the Treatment of Renal Disease in AA Amyloidosis

DOI

271

Citations

20

References

2007

Year

Laura M. Dember, Philip N. Hawkins, Bouke P. C. Hazenberg, Peter D. Gorevic, Giampaolo Merlini, İrena Butrimienė, Avi Livneh, O. M. Lesnyak, Xavier Puéchal, Helen J. Lachmann,
New England Journal of Medicine

Abstract

Eprodisate slows the decline of renal function in AA amyloidosis. (ClinicalTrials.gov number, NCT00035334.)

References

YearCitations

Page 1